HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Glazko, A. J. Articles by Holmes, E. L. Search for Related Content PubMed PubMed Citation Articles by Glazko, A. J. Articles by Holmes, E. L.

A New Analytical Procedure for Dapsone

Application to Blood-Level and Urinary-Excretion Studies in Normal Men

A new analytical procedure for the assay of DDS was based upon extraction into organic solvents and measurement of fluorescence in anhydrous ethyl acetate. Men receiving single 100-mg oral doses of DDS showed peak plasma levels of 1.1 to 1.5 µg per ml in 2 to 4 hours; the levels then dropped to half-values in 20.6 hours, and to a few millimicrograms per ml by the 5th day. Intramuscular doses of DADDS administered in an oil vehicle produced peak plasma levels of about 0.06 µg per ml in 6 days, and "plateau" levels of 0.035 to 0.030 µg per ml within 2 weeks. This level was maintained for about 60 days after dose, and dropped slowly thereafter with an apparent biological half-life of 42.6 days. The decrease in plasma levels occurred some 50-fold more slowly with DADDS than with orally administered DDS. The urinary excretion of "total" DDS ran parallel to the blood levels in both studies; it accounted for 68% of the oral dose of DDS and about 54% of the intramuscular dose of DADDS.